SE9403914D0 - Process B - Google Patents

Process B

Info

Publication number
SE9403914D0
SE9403914D0 SE9403914A SE9403914A SE9403914D0 SE 9403914 D0 SE9403914 D0 SE 9403914D0 SE 9403914 A SE9403914 A SE 9403914A SE 9403914 A SE9403914 A SE 9403914A SE 9403914 D0 SE9403914 D0 SE 9403914D0
Authority
SE
Sweden
Prior art keywords
factor viii
aqueous solution
pct
gel
present
Prior art date
Application number
SE9403914A
Other languages
English (en)
Other versions
SE503424C2 (sv
SE9403914L (sv
Inventor
Anna-Lisa Smeds
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9403914A priority Critical patent/SE503424C2/sv
Publication of SE9403914D0 publication Critical patent/SE9403914D0/sv
Priority to DK95937285T priority patent/DK0792281T3/da
Priority to AU39438/95A priority patent/AU691993B2/en
Priority to US08/809,698 priority patent/US6005082A/en
Priority to NZ295810A priority patent/NZ295810A/en
Priority to ES95937285T priority patent/ES2182915T3/es
Priority to DE69528471T priority patent/DE69528471T2/de
Priority to PT95937285T priority patent/PT792281E/pt
Priority to CA 2202873 priority patent/CA2202873C/en
Priority to PCT/SE1995/001350 priority patent/WO1996015140A1/en
Priority to AT95937285T priority patent/ATE225368T1/de
Priority to EP95937285A priority patent/EP0792281B1/en
Priority to JP51599296A priority patent/JP3871710B2/ja
Publication of SE9403914L publication Critical patent/SE9403914L/sv
Publication of SE503424C2 publication Critical patent/SE503424C2/sv
Priority to MXPA/A/1997/003470A priority patent/MXPA97003470A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SE9403914A 1994-11-14 1994-11-14 Process för rening av rekombinant koagulationsfaktor VIII SE503424C2 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9403914A SE503424C2 (sv) 1994-11-14 1994-11-14 Process för rening av rekombinant koagulationsfaktor VIII
JP51599296A JP3871710B2 (ja) 1994-11-14 1995-11-14 Ｖｉｉｉ因子の精製方法
DE69528471T DE69528471T2 (de) 1994-11-14 1995-11-14 Verfahren zur reinigung von faktor viii
CA 2202873 CA2202873C (en) 1994-11-14 1995-11-14 Process for purification of factor viii
US08/809,698 US6005082A (en) 1994-11-14 1995-11-14 Process for purification of factor VIII
NZ295810A NZ295810A (en) 1994-11-14 1995-11-14 Method of purifying factor viii using hydrophobic interaction chromatography gel with at least one surfactant in the chromatography solution
ES95937285T ES2182915T3 (es) 1994-11-14 1995-11-14 Procedimiento de purificacion del factor viii
DK95937285T DK0792281T3 (da) 1994-11-14 1995-11-14 Proces til oprensning af faktor VIII
PT95937285T PT792281E (pt) 1994-11-14 1995-11-14 Processo para a purificacao de factor viii
AU39438/95A AU691993B2 (en) 1994-11-14 1995-11-14 Process for purification of factor VIII
PCT/SE1995/001350 WO1996015140A1 (en) 1994-11-14 1995-11-14 Process for purification of factor viii
AT95937285T ATE225368T1 (de) 1994-11-14 1995-11-14 Verfahren zur reinigung von faktor viii
EP95937285A EP0792281B1 (en) 1994-11-14 1995-11-14 Process for purification of factor viii
MXPA/A/1997/003470A MXPA97003470A (en) 1994-11-14 1997-05-12 Factor v purification process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403914A SE503424C2 (sv) 1994-11-14 1994-11-14 Process för rening av rekombinant koagulationsfaktor VIII

Publications (3)

Publication Number Publication Date
SE9403914D0 true SE9403914D0 (sv) 1994-11-14
SE9403914L SE9403914L (sv) 1996-05-15
SE503424C2 SE503424C2 (sv) 1996-06-10

Family

ID=20395963

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9403914A SE503424C2 (sv) 1994-11-14 1994-11-14 Process för rening av rekombinant koagulationsfaktor VIII

Country Status (12)

Country Link
US (1) US6005082A (sv)
EP (1) EP0792281B1 (sv)
JP (1) JP3871710B2 (sv)
AT (1) ATE225368T1 (sv)
AU (1) AU691993B2 (sv)
DE (1) DE69528471T2 (sv)
DK (1) DK0792281T3 (sv)
ES (1) ES2182915T3 (sv)
NZ (1) NZ295810A (sv)
PT (1) PT792281E (sv)
SE (1) SE503424C2 (sv)
WO (1) WO1996015140A1 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2130554E (pt) 1999-02-22 2012-11-19 Univ Connecticut Formulações de factor viii isentas de albumina
US6822081B2 (en) * 2000-01-13 2004-11-23 Max-Planck Gesellschaft zur Förderung der Wissenschaften e.V. Process for the isolation and/or purification of a proteinaceous material
ES2343023T3 (es) 2000-03-27 2010-07-21 Genetics Institute, Llc Procedimientos para purificar proteinas altamente anionicas.
ATE421536T1 (de) * 2001-06-05 2009-02-15 Genetics Inst Llc Verfahren zur reinigung stark anionischer proteine
CA2542951C (en) * 2003-10-24 2016-08-30 Abhinav A. Shukla Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
JP5323072B2 (ja) * 2007-07-11 2013-10-23 ノボ・ノルデイスク・エー／エス 混合方式又は多様式樹脂を使用する第ｖｉｉｉ因子の精製
US20100168018A1 (en) 2008-11-07 2010-07-01 Baxter International Inc. Factor viii formulations
US8716448B2 (en) 2009-02-03 2014-05-06 Amunix Operating Inc. Coagulation factor VII compositions and methods of making and using same
RU2012151132A (ru) 2010-05-19 2014-06-27 Ф. Хоффманн-Ля Рош Аг Хроматография с гиброфобным взаимодействием
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN111548418A (zh) 2012-02-15 2020-08-18 比奥贝拉蒂治疗公司 因子viii组合物及其制备和使用方法
KR20190094480A (ko) 2012-02-15 2019-08-13 바이오버라티브 테라퓨틱스 인크. 재조합 인자 viii 단백질
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
TW202003554A (zh) 2013-08-14 2020-01-16 美商百歐維拉提夫治療公司 因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
JP6909203B2 (ja) 2015-08-03 2021-07-28 バイオベラティブ セラピューティクス インコーポレイテッド 第ｉｘ因子融合タンパク質及びそれらの製造方法及び使用方法
CN111183151A (zh) * 2017-06-23 2020-05-19 百深公司 因子viii亚种的纯化

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI86885C (sv) * 1984-04-20 1992-10-26 Genentech Inc Förfarande för framställning av human rekombinantfaktor VIII och nukle insyrasekvenser och vektorer använd därtill
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
US5595886A (en) * 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
GB9211538D0 (en) * 1992-06-01 1992-07-15 Blake David R Antiinflammatory agent
JP3905921B2 (ja) * 1992-10-02 2007-04-18 ジェネティクス インスチチュート リミテッド ライアビリティー カンパニー 凝固第▲ｖｉｉｉ▼因子を含む組成物及びその製造方法並びに安定剤としての界面活性剤の使用方法
JP3133338B2 (ja) * 1992-12-16 2001-02-05 イムノ・アクチエンゲゼルシャフト ウイルス的に安全な生物学的組成物の調製方法

Also Published As

Publication number Publication date
SE503424C2 (sv) 1996-06-10
US6005082A (en) 1999-12-21
PT792281E (pt) 2003-02-28
JP3871710B2 (ja) 2007-01-24
ATE225368T1 (de) 2002-10-15
DE69528471D1 (de) 2002-11-07
ES2182915T3 (es) 2003-03-16
WO1996015140A1 (en) 1996-05-23
MX9703470A (es) 1997-07-31
DK0792281T3 (da) 2003-02-03
SE9403914L (sv) 1996-05-15
EP0792281A1 (en) 1997-09-03
AU3943895A (en) 1996-06-06
JPH10508841A (ja) 1998-09-02
NZ295810A (en) 1998-08-26
EP0792281B1 (en) 2002-10-02
DE69528471T2 (de) 2003-07-10
AU691993B2 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
SE9403914D0 (sv) Process B
US5094960A (en) Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US4446134A (en) Process for heat treatment of aqueous solution containing human blood coagulation factor VIII
SE9603068D0 (sv) Process for purifying a protein
CN1125231A (zh) 用新的色谱分离条件纯化α-1蛋白酶抑制剂
ES2174957T3 (es) Proteinas purificadas de envoltura de virus de la hepatitis c para uso diagnostico y terapeutico.
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
ATE191922T1 (de) Feststellung der wechselwirkungsstelle zwischen p21-waf und pcna und deren therapeutischen verwendungen
EP0567448B2 (de) Verfahren zur Herstellung von Faktor VIII
EP0774261A2 (de) Verwendung von von Willebrand-Faktor und pharmazeutische Zubereitung
JPH0545600B2 (sv)
EP0117064A2 (en) Process for heat treatment of blood coagulation factor VIII
AT396937B (de) Verfahren zur aktivierung von blutgerinnungsfaktoren
ATE381577T1 (de) Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma
ATE190492T1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
US4769336A (en) Treatment of factor VIII inhibitors
KR950003312A (ko) 연골세포 단백질
JP2000032978A (ja) 液体からｈｉｖを分離する方法
KR970073604A (ko) 재조합 b형 간염 표면 항원의 정제방법
JP2678193B2 (ja) ヒト血漿由来血液凝固第ｘ▲ｉｉｉ▼因子の製造方法
CA1301680C (en) Process of preparing physiologically active proteinaceous solutions
DK563886A (da) Terapeutisk komposition
DE19616540A9 (de) Verwendung von von Willebrand-Faktor und pharmazeutische Zubereitung
KR910016339A (ko) Pp4-델타, 이의 제조방법 및 용도
DE19616540A1 (de) Verwendung von von Willebrand-Faktor und pharmazeutische Zubereitung

Legal Events

Date Code Title Description
NUG Patent has lapsed